Mastodon

Daigo (Liquid) Instructions for Use

Marketing Authorization Holder

Fyodorov Dmitry Vyacheslavovich, Sole Proprietor (Russia)

Manufactured By

B&S Corporation, Co. Ltd. (Japan)

Contact Information

B&S Corporation, Co. Ltd. (Japan)

Dosage Form

Bottle OTC Icon Daigo Oral liquid: sachets 5 ml 30 pcs.

Dosage Form, Packaging, and Product Composition

Liquid for oral administration, transparent, odorless, with a characteristic sourish taste.

Composition: fermented soy milk extract (culture fluid of 16 strains of lactic acid bacteria of the genus Lactobacillus), acidity regulators (lactic acid (E270), citric acid (E330)), menaquinone (vitamin K2).

Nutritional value (per 100 ml): fats – 0 g, proteins – 0 g, carbohydrates – 1.1 g.
Energy value: 4 kcal.

Does not contain live bacteria.
Does not contain GMOs.

5 ml – sachets (30) – cardboard boxes.

Therapeutic Category

Dietary supplement for restoring intestinal microflora

Properties

Metabiotic, helps restore gastrointestinal tract function and balance intestinal microflora.

The product consists of secretory secretions (bioregulators) obtained through co-cultivation of 16 strains of lactic acid bacteria of the genus Lactobacillus, with the addition of lactic acid and citric acid. Daigo is also an additional source of vitamin K2 – one of the metabolites of lactic acid bacteria. Daigo does not contain live lactobacilli.

Secretory secretions of lactobacilli revive the body’s own, unique intestinal microflora and promote the reproduction of beneficial bacteria, while simultaneously suppressing pathogenic microflora. Thus, pathogenic bacteria are replaced by beneficial ones, and the intestinal environment gradually improves.

Bacterial bodies – cellular substance, activates intestinal immune cells (Peyer’s patches) and helps stimulate the immune system, aiding in the control of immune balance throughout the body.

Vitamin K2 (menaquinone) is necessary for calcium absorption and blood clotting regulation. Some protein substances essential for our body can only be synthesized in the presence of menaquinone. Menaquinone supports cardiovascular health by redistributing calcium from the blood into bone tissue, regulating blood viscosity and coagulability. Consuming sufficient vitamin K2 prevents the formation of hard fatty deposits on the walls of blood vessels and arteries, ensuring normal blood circulation and protecting the heart. Vitamin K2 helps prevent calcification of coronary arteries, reduces the risk of coronary artery disease and other cardiovascular diseases. An additional effect resulting from improved vascular condition is the reduction of oxidative stress and improved brain function.

Bone and dental health directly depend on calcium level regulation. Menaquinone not only improves the absorption of this mineral but also helps transport it precisely to those areas of the body where calcium is most needed. The cause of brittle bones and teeth can be not only a calcium deficiency but also a lack of vitamin K2.

The use of Daigo product helps improve conditions in dysbiosis, chronic gastrointestinal diseases, allergic diseases, during antibacterial therapy, as well as in the treatment of diseases associated with Helicobacter pylori.

Scope of Application

Of Daigo product

As a dietary supplement – an additional source of vitamin K2, for the following diseases and conditions

  • Dysbiosis of various origins;
  • Prevention and treatment of diseases associated with Helicobacter pylori;
  • Chronic gastrointestinal diseases (colitis, gastritis, gastric and duodenal ulcer, irritable bowel syndrome, Crohn’s disease);
  • Colon polyps;
  • Antibiotic-associated diarrhea;
  • Impaired liver function;
  • Diabetes mellitus;
  • Allergic diseases;
  • Undergoing antibacterial, hormonal, and radiation therapy;
  • Prevention of complications and improvement of intestinal function during pregnancy;
  • Disturbance of the microflora of female genital organs (candidal vaginitis, inflammation of the cervix);
  • Stomatitis and dental caries;
  • Skin diseases (dryness, diathesis, atopic dermatitis).

ICD codes

ICD-10 code Indication
A04.7 Enterocolitis due to Clostridium difficile
B37.3 Candidiasis of vulva and vagina
B98.0 Helicobacter pylori as the cause of diseases classified elsewhere
D12 Benign neoplasm of colon, rectum, anus and anal canal
E14 Unspecified diabetes mellitus
K02 Dental caries
K12 Stomatitis and related lesions
K25 Gastric ulcer
K26 Duodenal ulcer
K29 Gastritis and duodenitis
K50 Crohn's disease [regional enteritis]
K51 Ulcerative colitis
K52.9 Noninfective gastroenteritis and colitis, unspecified
K58 Irritable bowel syndrome
K63.8 Other specified diseases of intestine
K76.9 Liver disease, unspecified
L20.8 Other atopic dermatitis (neurodermatitis, eczema)
N72 Inflammatory disease of cervix uteri (including cervicitis, endocervicitis, exocervicitis)
N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere
N89.8 Other noninflammatory disorders of vagina
R23.8 Other and unspecified skin changes
T78.4 Allergy, unspecified
Y40 Systemically acting antibiotics
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
Y84.2 Radiological procedure and radiotherapy

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

The product is taken orally before, during, or after meals, as well as on an empty stomach. Before use, the required dose of the product should be diluted in a glass of water.

The dose is set depending on age and increased/decreased as necessary

  • For breastfed infants – the nursing mother should take 1 sachet/day;
  • For formula-fed infants – add a few drops of the product to the formula (once/day);
  • For children aged 2 to 3 years – 1/5 sachet (1 ml)/day;
  • For children aged 3 to 6 years – 1/2 sachet (2.5 ml)/day;
  • For children aged 6 to 10 years – 1 sachet (5 ml)/day;
  • adults and children over 10 years are prescribed 3-5 sachets/day daily;

The recommended course of administration is 3 months. For solving some problems, a longer course of administration may be required – from 4 months to 1 year.

For prevention, the product can be used continuously.

Side Effects

No side effects have been identified.

Contraindications

  • Individual intolerance to the components;
  • Pregnancy;
  • Breastfeeding period.

Special Instructions

Dietary supplement, not a medicinal product.

Drug Interactions

Daigo can be taken simultaneously with other medications, however, it is recommended to consult with your doctor beforehand.

Dispensing Status

Places of sale are determined by the national legislation of the member states of the Eurasian Economic Union.

Storage Conditions

The product should be stored in a dry place, protected from sunlight, in a cool place at a temperature from 0°C (32°F) to 25°C (77°F).

Shelf Life

Shelf life – 3 years.

After opening the sachet, the product should be consumed within the day.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS